Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Francesca Danesi, PhD
Department of Agri-Food Sciences and Technologies, University of Bologna
Study Director - Luigi Ricciardiello, MD, Prof
Department of Medical and Surgical Sciences, University of Bologna
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- U.O. Gastroenterologia - Azienda Ospedaliero-Universitaria Di Bologna, Policlinico Sant'Orsola-Malpighi
Bologna, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jan 2017
- Primary completion
- 19 Jul 2023
- Completion
- 29 Dec 2023
- Last update posted
- 30 Aug 2023
- Registered enrollment
- 18
- Registry id
- NCT03000101
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.